Details for 2014763104
Up to date per 05.04.2026
Actions
Details for 2014763104
Granted/Registered
European Patent
20.01.2016 A
29.09.2021 B1
15.03.2013
US
201361800048 P
15.03.2013
US
201361800284 P
A61P 3/00 20060101AFI20210311BHEP
Owner
Protagonist Therapeutics, Inc.7707 Gateway Boulevard, Suite 140 Newark, CA 94560-1160US
Representative
Representative
WILDHACK & JELLINEK Patentanwälte GmbHLandstraßer Hauptstraße 501030 WienAT
Inventor
SMYTHE, Mark Leslie8 Morgan Terrace Bardon, Queensland 4065AU
BOURNE, Gregory Thomas29 Moolingal Street Jindalee, Queensland 4074AU
VINK, Simone5/70 Swann Road Taringa, Queensland 4068AU
FREDERICK, Brian T.8470 Glen Arbor Road Ben Lomond, CA 95005US
MADALA, Praveen55-Bilkurra Street Middle Park Brisbane, Queensland 4074AU
TOFTENG SHELTON, Anne PernillePrisholmvej 40 2500 ValbyDK
FOG, Jacob UlrikVaerebrovej 194 2880 BagsvaerdDK
Information about Fees